These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22435165)

  • 21. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
    Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
    Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases.
    Wu PC; Huang RL; Lang JH; Huang HF; Lian LJ; Tang MY
    Gynecol Oncol; 1991 Jan; 40(1):2-6. PubMed ID: 1846603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
    Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
    Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
    J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
    Mathew GK; Singh SS; Swaminathan RG; Tenali SG
    J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative treatment of ovarian cancer. Safety, ovarian function preservation, reproductive ability, and emotional attitude of the patients in Saudi Arabia.
    Sait KH
    Saudi Med J; 2011 Sep; 32(9):913-8. PubMed ID: 21894353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of ovarian malignant germ cell tumors with preservation of fertility.
    Long L; Jiang P; Liu FZ; Wang XP; Zhao TJ
    Chin Med J (Engl); 1993 Apr; 106(4):303-6. PubMed ID: 8325159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive function after treatment of ovarian germ cell malignancy.
    Anita AN; Rushdan MN
    Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of malignant germ cell tumors of the ovary.
    Chang FH; Lai CH; Chu KK; Chang TC; Hsueh S; Hung IJ
    J Formos Med Assoc; 1994 May; 93(5):411-6. PubMed ID: 7920081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
    Zhang N; Chen R; Hua K; Zhang Y
    J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.